600
Participants
Start Date
February 28, 2026
Primary Completion Date
May 31, 2029
Study Completion Date
June 30, 2029
Acetylsalicylic acid/Aspirin (100 mg)
Patients will receive 100 mg acetylsalicylic acid (or Aspirin) orally (tablet) once a day (or intravenously if oral administration is not possible in the acute phase of pneumonia), introduced within 84 hours of pneumonia diagnosis, for 90 days.
Placebo acetylsalicylic acid (100 mg) / 0.9% sodium chloride
patients in the placebo group will receive 100 mg placebo acetylsalicylic acid orally (tablet) once a day (or intravenously if oral administration is not possible in the acute phase of pneumonia), introduced within 84 hours of pneumonia diagnosis, for 90 days.
Centre Hospitalier Universitaire Dijon
OTHER